Filana Therapeutics, Inc. ( FLNA) - Key Metrics
FLNA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.18 | -$0.08 | -$0.08 |
| 2026Q1 | $0 | -$0.21 | $0 | $0 |
| 2025Q4 | $0 | -$0.26 | -$0.20 | -$0.21 |
| 2025Q3 | $0 | -$0.22 | -$0.13 | -$0.13 |
| 2025Q2 | $0 | -$0.92 | $0 | $0 |
FLNA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.65 |
| 2026Q1 | 0% | -2.01 |
| 2025Q4 | 0% | -1.97 |
| 2025Q3 | 0% | -2.33 |
| 2025Q2 | 0% | -0.56 |
FLNA
Price: $0.97
52 week price:
Earnings Per Share: -0.86 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 48.2 million